Title : Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study.

Pub. Date : 2012 Jan

PMID : 22740861






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens
2 Irinotecan hydrochloride (CPT-11) is reported to be involved in the downregulation of thymidylate synthase (TS), a target molecule of 5-fluorouracil (5-FU) and oral fluoropyrimidine S-1. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens
3 Irinotecan hydrochloride (CPT-11) is reported to be involved in the downregulation of thymidylate synthase (TS), a target molecule of 5-fluorouracil (5-FU) and oral fluoropyrimidine S-1. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens
4 Therefore, we hypothesized that a preceding administration of CPT-11 against S-1-resistant tumors may recover sensitivity to S-1. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens
5 Therefore, we hypothesized that a preceding administration of CPT-11 against S-1-resistant tumors may recover sensitivity to S-1. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens